Antibiotic Dosage Adjustments in CKD: Aminoglycosides, Vancomycin, and Renal Clearance

The short answer Chronic kidney disease (CKD) can change how long certain antibiotics remain in the body. When the kidneys clear a drug more slowly, the same dose may produce higher or more prolonged drug exposure. This is particularly important with aminoglycosides such as gentamicin and amikacin and with vancomycin, because excessive exposure can increase … Read more

Contrast Dye and Kidney Damage: What Is the Real Risk of Contrast-Induced Acute Kidney Injury in 2026?

The short answer Modern contrast dye does not automatically damage the kidneys. The risk depends strongly on the type of contrast, how it is given, your kidney function, and your overall medical condition. There is also an important terminology issue. A rise in creatinine after contrast is often called contrast-associated acute kidney injury (CA-AKI), but … Read more

Eating Out with Kidney Disease: Restaurant Strategies for Low-Sodium and Low-Potassium

Eating at a restaurant is possible with kidney disease. The key is not to avoid restaurants completely, but to make choices that fit your individual diet plan. Sodium is often the bigger restaurant challenge because prepared foods, sauces, processed meats, soups, and seasoning mixes can contain substantial amounts of sodium. Potassium is different: not everyone … Read more

Low-Protein Diets and Ketoanalogues in CKD: Can They Safely Delay Dialysis?

The short answer: Sometimes, but not for everyone, and not simply by eating as little protein as possible. For selected adults with moderate-to-advanced CKD who are not on dialysis, a carefully supervised low-protein diet may help reduce the risk of kidney failure. A very-low-protein diet combined with ketoanalogues may also slow kidney decline in some … Read more

Best Bread Options for Kidney Disease: Balancing Whole Grains, Sodium, and Phosphorus

The short answer: There is no single “best bread” for everyone with kidney disease. For many people with CKD, a lower-sodium whole-grain bread can be a good choice. But if you have high blood phosphorus, advanced CKD, dialysis, high potassium, or another dietary restriction, the best choice may be different. The important point is that … Read more

Fluid Restriction Rules for CKD: How to Calculate Daily Intake and Manage Thirst

The short answer: Not everyone with chronic kidney disease (CKD) needs to restrict fluids. In early CKD, the kidneys often still remove enough water that a fluid restriction is unnecessary. Fluid restriction becomes more relevant when kidney function is severely reduced, urine output falls, or excess fluid is accumulating because of conditions such as kidney … Read more

Is Oxalate a Concern for CKD Patients? Distinguishing Kidney Stones from Kidney Disease

The short answer: Oxalate can matter in CKD, but having CKD does not automatically mean you need a low-oxalate diet. Oxalate is a naturally occurring substance found in many foods. In the urinary tract, it can combine with calcium and form calcium oxalate kidney stones, the most common type of kidney stone. Most people with … Read more

Diuretics in CKD: Loop Diuretics vs Thiazides for Fluid Retention and Swelling

The short answer Diuretics (“water pills”) help the kidneys remove excess sodium and water through urine. They are commonly used in CKD when fluid retention causes swelling (edema), weight gain, high blood pressure, or shortness of breath from fluid overload. The choice between a loop diuretic and a thiazide or thiazide-like diuretic depends on the … Read more

Mineralocorticoid Receptor Antagonists (Kerendia/Finerenone) in Diabetic Kidney Disease

The short answer Finerenone (Kerendia) is a nonsteroidal mineralocorticoid receptor antagonist (MRA) used to reduce the risk of kidney and cardiovascular complications in certain adults with type 2 diabetes and chronic kidney disease (CKD). It is not simply a blood-pressure drug. Finerenone blocks the mineralocorticoid receptor, which can become overactive in diabetes and contribute to … Read more

SGLT2 Inhibitors (Farxiga, Jardiance) for CKD: How Diabetes Drugs Slow Kidney Decline

The short answer Farxiga (dapagliflozin) and Jardiance (empagliflozin) belong to a class of medicines called SGLT2 inhibitors. They were originally developed as diabetes medicines, but their benefits extend beyond lowering blood sugar. In appropriate people with chronic kidney disease (CKD), SGLT2 inhibitors can slow the loss of kidney function and reduce the risk of kidney … Read more